These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25596086)

  • 1. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
    Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
    Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
    Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
    Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
    PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
    Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis.
    Tian J; Pan F; Li J; Ma Y; Cen H; Pan HF; Pan YY; Ye DQ
    Asian Pac J Cancer Prev; 2012; 13(3):945-51. PubMed ID: 22631677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.
    Zhang M; Wu C; Li B; Du W; Zhang C; Chen Z
    Cancer Med; 2016 Apr; 5(4):760-6. PubMed ID: 26819081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.
    Sun Z; Ling M; Chang Y; Huo Y; Yang G; Ji Y; Li Y
    Connect Tissue Res; 2013; 54(1):55-61. PubMed ID: 23205884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
    Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
    J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
    Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.
    Zhang X; Miao X; Sun T; Tan W; Qu S; Xiong P; Zhou Y; Lin D
    J Med Genet; 2005 Jun; 42(6):479-84. PubMed ID: 15937082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
    Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.
    Zhao H; Zheng L; Li X; Wang L
    Sci Rep; 2014 Jan; 4():3866. PubMed ID: 24473454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
    Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
    Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
    Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
    J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
    Daripally S; Nallapalle SR; Katta S; Prasad VV
    Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
    J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.
    Park SH; Choi JE; Kim EJ; Jang JS; Lee WK; Cha SI; Kim CH; Kam S; Kim DS; Park RW; Kim YC; Han SB; Jung TH; Park JY
    Lung Cancer; 2006 Dec; 54(3):303-8. PubMed ID: 17014925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.